MetaLabs Posts KRW 98.7 Billion in Cumulative Q3 Revenue, Up 97% YoY

KOSPI-listed MetaLabs achieved both revenue growth and improved profitability on a cumulative basis through the third quarter of this year. Revenue from its core fashion business increased substantially, while subsidiary Momolabs, which operates a management services organization (MSO) business for hair-loss clinics, also swung to a profit, contributing to the improved results.

MetaLabs said it recorded consolidated revenue of KRW 98.7 billion and operating profit of KRW 2.5 billion on a cumulative basis through the third quarter of 2026. Revenue rose 97% and operating profit increased 140% from the same period a year earlier. The net loss narrowed by about KRW 4.7 billion, from KRW 6.3 billion in the same period last year to KRW 1.6 billion.

The fashion division, the company's core business, led growth. Fashion business revenue in the third quarter rose 129% from a year earlier. Revenue increased as the company expanded its premium brand licensing and distribution businesses through major shopping channels, including Lotte Home Shopping, GS SHOP and KT Alpha Shopping. The company plans to sustain this growth by diversifying its brand portfolio and expanding its distribution channels.

Subsidiary Momolabs also contributed to improved profitability. Momolabs, which operates an MSO business for hair-loss clinics, posted a profit in the third quarter as operating profit improved 170% from a year earlier. MetaLabs plans to strengthen the competitiveness of its medical institution management support business and establish a stable profit base by improving operational efficiency.

The expansion of the consolidated entities also contributed to the increase in results. From June, the results of TechLabs, an artificial intelligence (AI)-based adtech and digital healthcare company, and its major affiliates were included in the consolidated financial statements. In July, JK Medi, acquired by subsidiary MetaCare, was also added to the consolidation.

Building on growth in its existing businesses, MetaLabs plans to accelerate the expansion of its hair-loss healthcare business. The company aims to build a hair-loss healthcare ecosystem and expand synergies among its affiliates by connecting its MSO business with pharmaceutical and medical device supply, customer relationship management (CRM) solutions tailored to medical institutions, medical data and AI technologies.

The company is also pursuing an AI hair transplant robot business. On October 13, MetaLabs signed a memorandum of understanding (MOU) with Fengche Robotics, a Chinese medical robotics specialist, and is working to advance research and development (R&D), regulatory approvals and commercialization of AI hair transplant robots in Korea and overseas. The strategy is to expand its existing hair-loss healthcare business into the physical AI field and secure new growth drivers.

A MetaLabs official said, "Strong revenue growth in our core fashion business and improved profitability in our hair-loss medical business are contributing to our growth in results. We will strengthen the competitiveness of our existing businesses and maximize synergies among our affiliates to establish a stable profit base, while expanding our mid- to long-term growth drivers by further developing the hair-loss healthcare ecosystem."

This content was produced with the assistance of AI translation services.